ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising breakthroughs across various health care and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, more responsible alternate for therapeutic use, spe